Projects overview

Sort by


Toggle all information

HERVCOV | SARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personalized treatment of COVID-19 patients

01-07-2022

-

30-06-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-07 Personalised medicine and infectious diseases: understanding the individual host response to viruses (e.g. SARS-CoV-2)

REACT | Respiratory Host-Pathogen Interaction

01-08-2022

-

31-07-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-07 Personalised medicine and infectious diseases: understanding the individual host response to viruses (e.g. SARS-CoV-2)

HORUS | Casting light on HOst-cytomegaloviRUs interaction in Solid organ transplantation

01-11-2022

-

31-10-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-07 Personalised medicine and infectious diseases: understanding the individual host response to viruses (e.g. SARS-CoV-2)

D-SOLVE | Understanding the individual host response against Hepatitis D Virus to develop a personalized approach for the management of hepatitis D

01-10-2022

-

30-09-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-07 Personalised medicine and infectious diseases: understanding the individual host response to viruses (e.g. SARS-CoV-2)

EDCTP Africa Office | Strengthening global cooperation and institutional capacities in sub-Saharan Africa to facilitate implementation of the GH EDCTP3 programme

01-01-2023

-

31-12-2025

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-JU-EDCTP3-2022-GH-Africa-IBA HORIZON-JU-GH-EDCTP3-2022-OA1 Grant to identified beneficiary - Support for an Africa office

EPIVINF | Epigenetic regulation of host factors in viral infections (EPIVINF)

01-09-2022

-

31-08-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-07 Personalised medicine and infectious diseases: understanding the individual host response to viruses (e.g. SARS-CoV-2)

HoliCare | A holistic approach in patient management and epidemic surveillance through convergence of diagnostic technologies, capacity building and stakeholder engagement

01-09-2022

-

31-08-2025

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-03 Innovative approaches to enhance poverty-related diseases research in sub-Saharan Africa

NEUROCOV | The pandemic within: tackling brain vulnerability in COVID19 at high resolution: NEUROCOV

01-09-2022

-

31-08-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-07 Personalised medicine and infectious diseases: understanding the individual host response to viruses (e.g. SARS-CoV-2)

PvSTATEM | SEROLOGICAL TESTING AND TREATMENT FOR P. VIVAX: FROM A CLUSTER-RANDOMISED TRIAL IN ETHIOPIA AND MADAGASCAR TO A MOBILE-TECHNOLOGY SUPPORTED INTERVENTION

01-10-2022

-

30-09-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-03 Innovative approaches to enhance poverty-related diseases research in sub-Saharan Africa

ECRAID-PRIME | European Clinical Research Alliance on Infectious Diseases - PRIMary care adaptive platform trial for pandemics and Epidemics

01-12-2021

-

30-11-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-CORONA-01
HORIZON-HLTH-2021-CORONA-01-02 Cohorts united against COVID-19 variants of concern

DESIGN OH AMR | DESIGNing the European Partnership on One Health AMR

01-05-2022

-

30-09-2024

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-05 A roadmap towards the creation of the European partnership on One Health antimicrobial resistance (OH AMR)

XVR011 Phase 2 | ExeVir's XVR011, a best in class nanobody-based biology that broadly neutralizes SARS-COV-1 and SARS-COV-2

01-12-2021

-

30-11-2022

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-CORONA-01
HORIZON-HLTH-2021-CORONA-01-01 Vaccines & therapeutic clinical trials to boost COVID-19 prevention and treatment

COVend | Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stages of COVID-19

01-08-2021

-

31-01-2025

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-CORONA-01
HORIZON-HLTH-2021-CORONA-01-01 Vaccines & therapeutic clinical trials to boost COVID-19 prevention and treatment

DUALSAVE-FGS | Dual screening by Spectral Artificial Visual Examination (SAVE) for Female Genital Schistosomiasis (FGS) and cervical cancer. Digital, new, low-cost, and simple screening and training.

01-08-2022

-

31-07-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-03 Innovative approaches to enhance poverty-related diseases research in sub-Saharan Africa

TiilT | Preclinical development of a 3rd-generation interleukin-2 targeted to inflammatory sites

01-06-2023

-

31-05-2028

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

PHOENIX | NANOMEDICINE FOR ORGAN TRANSPLANTATION TOLERANCE (PHOENIX)

01-04-2023

-

31-03-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

IMMUTOL | ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES

01-05-2023

-

30-04-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

NEXGEN-PD | Next Generation Vaccine Platform Leveraging Skin Immunity to Provide Disease-Modifying Treatment of Parkinson’s Disease

01-04-2023

-

31-03-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

UltiMalVax | A Vaccine Targeting Eradication of Malaria

01-05-2023

-

30-04-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-03-two-stage Vaccines 2.0 - developing the next generation of vaccines
Powered by Chris Decubber BV